Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II Clinical Trial of Celecoxib /OR Nsaid/ for Prevention of Spor-261995015
Strang Cancer Prevention Cent
Search grants from Strang Cancer Prevention Cent
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Identification and Characterization of Liver Cancer Stem Cells
Effect Of Drugs of Abuse On Synaptic Transmission In Nucleus Accumbens
In vivo microarray analysis of Neurogenesis
Neuron Specific Neuropeptide Hormone Gene Expression
Phase II Trial of IL-1 Alpha + Indomethacin in Melanoma Patients
Recently added grants:
Quantifying the role of adaptation in olfactory coding through the logic of navigation
Genetic Strategies for Neurodevelopmental Research
Communicating narrative Concerns entered by RNs (CONCERN)
Fluctuations in Ionic Current through Membrane Channels
Membrane Curvature Sensing Mechanisms for Synaptic Vesicle Endocytosis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN995015-003
Application #
7329495
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2006
Total Cost
Indirect Cost
Institution
Name
Strang Cancer Prevention Cent
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2006
N01 CN
Phase II Clinical Trial of Celecoxib /OR Nsaid/ for Prevention of Spor-261995015
/ Strang Cancer Prevention Cent
NIH 2004
N01 CN
Phase II Clinical Trial of Celecoxib /OR Nsaid/ for Prevention of Spor-261995015
/ Strang Cancer Prevention Cent
Comments
Be the first to comment on this grant